US EditionApple Ordered To Pay Masimo US$634 Million Over Patent Dispute
6 Articles
6 Articles
The jury ruled in favor of Masimo, which sued Apple Watch over its blood oxygen measurement, but the verdict is not final.
Apple Watch once again includes an essential health function after several months of absence, but this return immediately to the centre of the attention of the North American authorities.
Masimo’s $634 million win and what it means for Apple Watch
A U.S. jury has ordered Apple to pay Masimo $634 million after finding it infringed patents tied to health monitoring. At issue were patents covering pulse oximeter functionality used in Apple Watch models, and whether that qualifies as part of a “patient monitoring” device. The decision arrives after quite a bit of legal manoeuvring. It also lands at a time when users in the United States are still dealing with restricted on device SpO2 functio…
Apple Ordered To Pay Masimo US$634 Million Over Patent Dispute
A federal jury in California has ruled that Apple must pay US$634 million (about RM2.62 billion) to medical-technology company Masimo after finding that several Apple Watch features infringed on one of Masimo’s blood-oxygen monitoring patents. The verdict, first reported by Reuters, marks a significant development in a long-running and highly complex legal fight between the two companies. The case centres on Masimo’s patent covering blood-oxygen…
A US Federal Jury condemned Apple to pay $634 million to the medical technology company Masimo for the violation of a patent related to the blood oxygen sensor of Apple Watch. Apple immediately announced its intention to appeal this verdict. A victory for Masimo, a decision contested by Apple In [...] Read more... Follow iPhoneAddict.fr on Facebook, and follow us on Twitter Don't forget to download our free iAddict app for iPhone and iPad (link …
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
